2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Hyponatremia: new trials by email Literature Review of Hyponatremia trials Research Report on Hyponatremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium Cicletanine + magnesium, Cicletanine - Arterial Hypertension, Diabetes | Phase 1 / Phase 2 | Unknown | Navitas Pharma | 24 | 2022-06-01 | 2021-09-05 |
| Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: HTS 3%, Standard fluid management - Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 1 / Phase 2 | Unknown | Thomas Jefferson University | 50 | 2015-01-01 | 2016-02-11 |
Diabetes Mellitus (1) · Hypertension (1) · Hypokalemia (1) · Metabolic Diseases (1) · Subarachnoid Hemorrhage (1) · Vasospasm, Intracranial (1)
Cardiovascular Diseases (2) · Nutritional and Metabolic Diseases (2) · Vascular Diseases (2) · Water-Electrolyte Imbalance (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hemorrhage (1) · Intracranial Hemorrhages (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
5-(3-hydroxybenzoyl)-2-thiophenesulfonamide (1) · Magnesium (1) · cicletanine (1)
Navitas Pharma (1) · Thomas Jefferson University (1)
United States (1)